BiondVax
BVXV
$1.36
Share price
0.74%
Change (1 day)
-37.33%
Change (1 year)
Categories
BiondVax (BVXV) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $27 M
According to BiondVax's latest financial reports the company's total liabilities are $27 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
BiondVax - Total liabilities on balance sheet (from 2022 to 2022)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $28.82 M | 17.33% |
| 2021-12-31 | $24.56 M | 255% |
| 2020-12-31 | $6.92 M | -86.76% |
| 2019-12-31 | $52.26 M | 440.36% |
| 2018-12-31 | $9.67 M | 30.77% |
| 2017-12-31 | $7.39 M | 525.38% |
| 2016-12-31 | $1.18 M | -40.63% |
| 2015-12-31 | $1.99 M | 313.49% |
| 2014-12-31 | $0.48 M | -8.93% |
| 2013-12-31 | $0.52 M | 93.77% |
| 2012-12-31 | $0.27 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | 3.37% | 🇺🇸 USA |